Showing results (1971-1980 of 2,007) with videos related to
Sort By:
Pageof 201
The Lancet. Infectious Diseases|September 25, 2023
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Peta Edler, et al.The Lancet. Infectious Diseases|October 1, 2023
Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trialWilliam H K Schilling, Podjanee Jittamala, James A Watson, et al.The Journal of Infectious Diseases|July 20, 2023
Clinical Antiviral Efficacy of Remdesivir in Coronavirus Disease 2019: An Open-Label, Randomized Controlled Adaptive Platform Trial (PLATCOV)Podjanee Jittamala, William H K Schilling, James A Watson, et al.Eclinicalmedicine|February 3, 2025
Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)Podjanee Jittamala, Simon Boyd, William H K Schilling, et al.Cell Reports|August 9, 2018
Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast CancerJonathan T Lei, Jieya Shao, Jin Zhang, et al.Nature|January 13, 2012
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingLi Ding, Timothy J Ley, David E Larson, et al.The New England Journal of Medicine|November 12, 2010
DNMT3A mutations in acute myeloid leukemiaTimothy J Ley, Li Ding, Matthew J Walter, et al.Scientific Data|April 18, 2025
ROBIN: Reference observatory of basins for international hydrological climate change detectionS Turner, J Hannaford, L J Barker, et al.Cell|July 24, 2012
The origin and evolution of mutations in acute myeloid leukemiaJohn S Welch, Timothy J Ley, Daniel C Link, et al.Nature Immunology|December 2, 2021
An immunodominant NP<sub>105-113</sub>-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 diseaseYanchun Peng, Suet Ling Felce, Danning Dong, et al.Pageof 201